AZT.OL Tiesioginiai signalai | Didinkite pelną su Getagraph.com

PIRKIMAS 1381 min ago

@ NOK25.80

Išleistas: 26 bal. 2024 @ 15:41

Grąža: 0.78%

Ankstesnis signalas: bal. 26 - 15:23

Ankstesnis signalas: Pardavimas

Grąža: -0.39 %

Live Chart Being Loaded With Signals

Commentary (26 bal. 2024 @ 17:25):
Our systems believe the stock currently is overvalued by 0.01% compare to its pairs and should correct downwards.

ArcticZymes Technologies ASA, a life sciences company, develops, manufactures, and commercializes recombinant enzymes for use in molecular research, In vitro diagnostics, and biomanufacturing...

Stats
Šios dienos apimtis	23 429.00
Vidutinė apimtis	38 638.00
Rinkos kapitalizacija	1.32B
EPS	NOK0 ( 2024-01-31 )
Kita pelno data	( NOK0.0700 ) 2024-05-07
Last Dividend	NOK0 ( N/A )
Next Dividend	NOK0 ( N/A )
P/E	76.47
ATR14	NOK1.250 (4.84%)

Koreliacija (AI algo v.1.1b): Overvalued: -0.01% NOK25.80 paired level. (Algoritmas realiuoju laiku stebi didžiausią koreliaciją turinčių akcijų pokyčius ir suteikia momentinę informaciją)

Tūris Koreliacija

Ilgas: -0.99 (very strong negative)

Trumpas: 0.00 (neutral)

Signal:(0) Neutral

Arcticzymes Technologies Koreliacija

10 Labiausiai teigiamai susiję koreliacijos
EQNR.OL	0.878
OTS.OL	0.855
CADLR.OL	0.847
XXL.OL	0.846
BEWI.OL	0.841
TOM.OL	0.839
MULTI.OL	0.819
VAR.OL	0.819
B2H.OL	0.818
NAVA.OL	0.815

10 Labiausiai neigiamai susiję koreliacijos
ZAL.OL	-0.882
SIOFF.OL	-0.876
FROY.OL	-0.86
SOAG.OL	-0.859
PROT.OL	-0.852
VEI.OL	-0.85
ODL.OL	-0.837
SALM.OL	-0.833
SVEG.OL	-0.83
PGS.OL	-0.83

Ar žinojote?

Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).

Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.

Arcticzymes Technologies Koreliacija - Valiuta/Žaliavos

-0.74
( moderate negative )

-0.63
( weak negative )

0.00
( neutral )

-0.77
( moderate negative )

0.00
( neutral )

0.60
( weak )

Arcticzymes Technologies Finansinės ataskaitos

Annual	2023
Pajamos:	NOK118.94M
Bruto pelnas:	NOK47.77M (40.16 %)
EPS:	NOK0.370

FY	2023
Pajamos:	NOK118.94M
Bruto pelnas:	NOK47.77M (40.16 %)
EPS:	NOK0.370

FY	2022
Pajamos:	NOK136.97M
Bruto pelnas:	NOK131.79M (96.22 %)
EPS:	NOK0.650

FY	2021
Pajamos:	NOK127.97M
Bruto pelnas:	NOK124.09M (96.96 %)
EPS:	NOK0.940

Financial Reports:

No articles found.

Arcticzymes Technologies

ArcticZymes Technologies ASA, a life sciences company, develops, manufactures, and commercializes recombinant enzymes for use in molecular research, In vitro diagnostics, and biomanufacturing. It offers salt active nuclease for the removal of nucleic acids during manufacturing of viral vectors, recombinant proteins, and other reagents; shrimp alkaline phosphatase and derived kits for cleanup prior to Sanger sequencing and next generation sequencing processes; cod UNG for use in viral and other molecular diagnostic assays; double-strand specific DNases and derived kits for the removal of double stranded DNA; polymerases for technology development for life science, molecular diagnostics, NGS, and synthetic biology; proteinase for microbiological diagnostics and liquid biopsies; and ligases for joining DNA /RNA fragments. It operates in Norway, Germany, Lithuania, Italy, other countries in Europe, the United States, and internationally. The company was formerly known as Biotec Pharmacon ASA and changed its name to ArcticZymes Technologies ASA in June 2020. ArcticZymes Technologies ASA was incorporated in 1990 and is headquartered in Tromsø, Norway.